Understanding genetic risk and the pathogenesis of Covid-19 through polygenic risk scores
New work looking at genetic risk and the links with inflammatory disease and COVID-19 will not only help predict those patients at more severe risk...
Search results for “”
Results 1 to 10 of 14
Improving ovarian cancer care through AI
A team of research fellows led by Professor Geoff Hall is developing AI tools to support ovarian cancer research in Leeds. The work aims to...
Multi-disease pathways
With improved care and treatment, more individuals are living longer after their heart attack. Unfortunately this means that the chance of developing other conditions over...
Building partnerships with supermarkets to create lasting change in nutrition and health
Work using supermarket food purchase data to build upon and develop new approaches to using digital lifestyle data in health research is being undertaken by...
Bringing pathology practice up to date
Digital pathology is by no means a new practice; pathologists have had the ability to scan and digitise an entire pathology glass slide for...
Could loyalty cards improve our public health?
The use of supermarket loyalty cards and mobile phone apps tracking diet or exercise are increasingly pervasive. Not only do they provide a useful...
Finding the bigger picture behind heart attacks
The number of people surviving heart attacks has improved enormously in recent decades – but little is known about what happens to patients afterwards....
Melanoma and Big Data
Introduction All cancers are different. Some, arise from relatively well-understood changes (or mutations) in a patient’s genetic code. Melanoma, on the other hand, appears very differently...
Identification of clinical factors associated with poor surgical outcomes in a primary care dataset
Introduction There are 310 million surgeries worldwide per year, there is a 1-5% short-term mortality and 20% post-surgical complications rate. Aims of the study are...
Early economic modelling and budget impact analysis of Prolaris® test to aid the treatment management decisions in prostate cancer patients
Introduction To accurately stratify patients with localized prostate cancer according to disease aggressiveness and mortality, Myriad Genetics Inc. developed Prolaris®, a prognostic test that directly...